Project Details
| Short title | Evaluating the Role of Minimal Residual Disease Monitoring in Predicting Outcome After Reduced Intensity Allografts in AML |
|---|---|
| Status | Finished |
| Effective start/end date | 1/02/15 → 31/01/18 |
Funding
- BLOODWISE
Evaluating the Role of Minimal Residual Disease Monitoring in Predicting Outcome After Reduced Intensity Allografts in AML
- Craddock, Charles (Principal Investigator)
- Freeman, Sylvie (Co-Investigator)
- Raghavan, Manoj (Co-Investigator)
- Wheatley, Keith (Co-Investigator)